IL-33-dependent tumor-infiltrating ILC2s have been demonstrated to mediate tumor immune surveillance in cooperation with DCs in promoting adaptive cytolytic T cell responses and controlling tumor metastasis in mice [142]. The gene discussed is IL33; the disease is neoplasm.